ID: ALA5284072

Max Phase: Preclinical

Molecular Formula: C30H27NO2

Molecular Weight: 433.55

Associated Items:

Representations

Canonical SMILES:  O=C(O)/C=C/c1c(-c2ccc(CCc3ccccc3)cc2)c(-c2ccccc2)c2n1CCC2

Standard InChI:  InChI=1S/C30H27NO2/c32-28(33)20-19-27-30(29(24-10-5-2-6-11-24)26-12-7-21-31(26)27)25-17-15-23(16-18-25)14-13-22-8-3-1-4-9-22/h1-6,8-11,15-20H,7,12-14,21H2,(H,32,33)/b20-19+

Standard InChI Key:  NERFLINBYIHYSS-FMQUCBEESA-N

Associated Targets(Human)

Cyclooxygenase-1 9233 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Arachidonate 5-lipoxygenase 6568 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cyclooxygenase-1 167 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 433.55Molecular Weight (Monoisotopic): 433.2042AlogP: 6.65#Rotatable Bonds: 7
Polar Surface Area: 42.23Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.54CX Basic pKa: CX LogP: 7.44CX LogD: 4.66
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.33Np Likeness Score: -0.17

References

1. Gouda AM, Abdelazeem AH..  (2016)  An integrated overview on pyrrolizines as potential anti-inflammatory, analgesic and antipyretic agents.,  114  [PMID:26994693] [10.1016/j.ejmech.2016.01.055]

Source